Diagnostic journey for patients with infantile Krabbe Disease and late-onset Krabbe Disease


Bilen M., Teke Kısa P., Yıldız S., Er E., Olgaç Kılıçkaya M. A. B., Kocabey M., ...Daha Fazla

International Congress of Inborn Errors of Metabolism 2025, Kyoto, Japonya, 2 - 06 Eylül 2025, (Yayınlanmadı)

  • Yayın Türü: Bildiri / Yayınlanmadı
  • Basıldığı Şehir: Kyoto
  • Basıldığı Ülke: Japonya
  • Dokuz Eylül Üniversitesi Adresli: Evet

Özet

Introduction

Krabbe disease(KD; OMIM #245200) is a lysosomal storage disorder caused by deficiency of  galactocerebrosidase(GALC; EC 3.2.1.46) encoded by GALC gene. Based on the age of onset, KD is divided into early-onset and late-onset forms. The early-infantile form accounts for about 80% of cases. It is characterised by severe neurological symptoms including hyperirritability, feeding difficulties, axial hypotonia, lower limb spasticity, peripheral neuropathy and clonus. The adult-onset form progresses more slowly with predominant features of  sensorimotor polyneuropathy and spastic paraplegia. The aim of this study was to evaluate the clinical and molecular features of patients diagnosed with KD.

 

Material and Methods

This cross-sectional descriptive study was conducted in four metabolic centres in Turkey, with data collected between 2020-2024. Patient demographics, physical examination and laboratory results, and GALC gene molecular analyses were retrospectively reviewed.

 

Results

Of the ten patients included, five were male and eight had a history parental consanguinity. Among the five early infantile KD cases, the median age of symptom onset was 5 months (range: 3.5-12 months) and the median age at diagnosis was 9 months (range: 5-36 months). Two siblings presented with regression of acquired skills, and the remaining patients presented with loss of head control, seizures and feeding difficulties. Three patients died from disease-related complications -two from aspiration and sepsis at 39 and 44 months, and one from sudden infant death at 9 months. The two surviving patients had significant developmental delays  and required nasogastric feeding. One underwent a ventriculoperitoneal shunting for  hydrocephalus.

The late-onset KD group included two siblings diagnosed at 8 and 12 years of age, both of whom had early seizures(at 18 and 24 months) followed by developmental regression. Electromyography revealed myopathy, and follow-up examinations revealed developmental delay, dystonia, dysmetria, dysdiadochokinesia and gait disturbance. One male patient was diagnosed at the age of 52 years after presenting with muscle weakness at the age of 35 years. Electromyography showed progressive polyneuropathy and cranial MRI showed white matter hyperintensities and cortical atrophy on T2-weighted images. Family screening identified GALC gene variants in two out of four offspring.

 

CONCLUSION

In this study, all patients with late-onset KD were diagnosed using whole exome sequencing (WES) highlighting the utility of WES  in identifying atypical presentations of KD.  This study documents the clinical course of early infantile KD and highlights the importance of considering inherited metabolic disorders, in adult patients with unexplained neurological symptoms.